Am J Transplant, Volume 19, Suppl 3 Archives - Page 212 of 214 - ATC Abstracts

2019 American Transplant Congress
Caregiving before Thoracic Transplantation–A Qualitative Inquiry
C. C. Kennedy¹, J. Ridgeway¹, E. Stevens¹, J. Kirsch², K. Carroll¹, J. Griffin¹, R. Benzo¹
¹Mayo Clinic, Rochester, MN, ²University of Florida-Gainesville, Gainesville, FL
*Purpose: Although post-transplant caregiver (CG) support is a prerequisite for transplant listing, research shows CG outcomes including stress and social functioning may be worse during…
2019 American Transplant Congress
Comparison of Basiliximab and Alemtuzumab for Lung Transplant Induction
S. Mietz¹, D. Roe², E. Lushin¹, E. Anderson¹, C. Hage²
¹Pharmacy, Indiana University Health, Indianapolis, IN, ²Pulmonary Critical Care, Indiana University Health, Indianapolis, IN
*Purpose: Compare alemtuzumab and basiliximab used for lung transplant in terms of rejection, CLAD, and mortality.*Methods: A retrospective review of lung transplants performed between 2010…
2019 American Transplant Congress
Robotic Pancreas Kidney Transplantation For Type 1 Diabetic Patient With End stage Renal Disease: First Year Experience In Single Institute
S. Lee¹, L. A. Cantrell², A. Agarwal¹, S. K. Rasmussen¹, S. Pelletier¹, K. Brayman¹, J. Oberholzer¹
¹Division of Transplant Surgery, Department of Surgery, University of Virginia Health Sciences Center, Charlottesville, VA, ²Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Virginia Health Sciences Center, Charlottesville, VA
*Purpose: Simultaneous pancreas kidney transplantation for type 1 diabetic patients with end-stage renal disease is a highly successful, but also very invasive surgical procedure. Robotic…
2019 American Transplant Congress
The Use of Mobile Software for Real-Time, Secure, Team-Based Procurement and Transplantation Team Communication to Improve the Deceased Donor Organ Transplantation Process
E. Pahl
HealthTech Solutions, Inc., Coralville, IA
*Purpose: Deceased donor organ (DDO) transplantation is an effective cure for patients suffering from organ failure. Organ transplantation is cost-effective, provides a significant survival benefit,…
2019 American Transplant Congress
Pharmacist Impact on Vaccinations Rates in Cardiothoracic Transplant Recipients
K. Zaborowski, J. Dedering, R. Felkner
William S. Middleton Memorial Veterans Hospital, Madison, WI
*Purpose: The purpose of this project is to determine the impact pharmacists have on cardiothoracic transplant recipients’ vaccination status at the time of transplant surgery.*Methods:…
2019 American Transplant Congress
Donor Derived Neoplasia: Will It Be a Risk after Clinical Pig Organ Xenotransplantation?
A. Jagdale¹, H. Iwase¹, E. Klein², D. Cooper¹
¹Surgery, University of Alabama at Birmingham, Birmingham, AL, ²Surgery, University of Pittsburgh, Pittsburgh, PA
*Purpose: The survival of the nonhuman primates with life-supporting pig kidney grafts has increased substantially (to >1 year). As clinical pig organ xenotransplantation draws closer,…
2019 American Transplant Congress
Infectious Complications after Treatment of Antibody-Mediated Kidney Allograft Rejection: A National Cohort Study
N. Perrottet¹, D. Golshayan², O. Manuel², V. Aubert², M. Koller³, K. Hadaya⁴, L. Bühler⁴, T. Mueller⁵, U. Huynh-Do⁶, S. Dahdal⁶, I. Binet⁷, M. Dickenmann³, S. Schaub³, J. Steiger³, M. Pascual², M. Fernández-Ruiz²
¹Pharmacy, CHUV, Lausanne, Switzerland, ²CHUV, Lausanne, Switzerland, ³USB, Basel, Switzerland, ⁴HUG, Geneva, Switzerland, ⁵USZ, Zurich, Switzerland, ⁶Inselspital, Bern, Switzerland, ⁷KSSG, St. Gallen, Switzerland
*Purpose: Multimodal therapeutic strategies used to treat acute antibody-mediated rejection (AMR) could enhance the risk of infection. However, data in this context are scarce.*Methods: We…
2019 American Transplant Congress
Favorable Outcome of Pathologic Downstaging by Locoregional Treatment for Hepatocellular Carcinoma in Liver Transplantation
D. Kim, J. Lee, S. Kim, K. In, D. Joo, S. Kim, M. Kim
Severance hospital, Seoul, Korea, Republic of
*Purpose: There was no distinct guideline how to take into account the effect of pretransplant locoregional treatment (LRT) in hepatocellular carcinoma (HCC) staging system. The…
2019 American Transplant Congress
Leukopenia at the Time of Liver Transplantation: Medication Tolerance and Clinical Outcomes
E. Tiao¹, J. Casale¹, J. LaMattina², S. Hammad¹
¹Pharmacy, University of Maryland Medical Center, Baltimore, MD, ²Surgery, University of Maryland School of Medicine, Baltimore, MD
*Purpose: Leukopenia post-orthotopic liver transplant (OLT) is associated with an increased incidence of infection and mortality. Prior to OLT, leukopenia may suggest innate immunosuppression and…
2019 American Transplant Congress
Cd45rb Mediates Cd8⁺T Cell Persistence In An Allogeneic Heterologous Immune Response
S. M. Krummey, A. B. Morris, M. L. Ford
Emory Transplant Center, Atlanta, GA
*Purpose: Memory T cells primed with microbial antigen can cross-react with alloantigen and mediate graft rejection, a process termed allogeneic heterologous immunity. Human and murine…